## Abstract ## Background. Treatment of head and neck squamous cell carcinoma (HNSCC) addresses the primary tumor and the lymphatic drainage. Modalities for the neck are neck dissection and/or radiation therapy. In most cases, the neck is treated by the modality that seems more appropriate for the
Serologic determinants of survival in patients with squamous cell carcinoma of the head and neck
β Scribed by Gary L. Clayman; Howard E. Savage; Nancy Ainslie; Frank J. Liu; Stimson P. Schantz
- Book ID
- 117024489
- Publisher
- Elsevier Science
- Year
- 1990
- Tongue
- English
- Weight
- 500 KB
- Volume
- 160
- Category
- Article
- ISSN
- 0002-9610
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background We have shown that rILβ2 administration in recurrent head and neck cancers induces a tumorβspecific Tβlymphocyte reactivity and tumor regression; in a pilot study we have shown a safe and effective administration of rIL2 after cisplatin + 5βfluorouracil. Longβterm results
## Background: There is a need for a classification system for prognosis based on the tnm system for patients with squamous cell carcinoma of the head and neck such that patient groupings are homogeneous within and heterogeneous between. ## Methods: Six hundred fifty-five consecutive patients wit